| REVIEW ARTICLES |
|
| Year : 2022 | Volume
: 2
| Issue : 1 | Page : 9-14 |
|
|
Evaluation of diabetic neuropathies
Amit Varma1, Kapil Sharma2, Sumita Sharma3
1 Department of General Medicine, SGRRIM&HS, Dehradun, Uttarakhand, India
2 Department of General Medicine, AIIMS, Bilaspur, Himachal Pradesh, India
3 Department of Biochemistry, AIIMS, Bilaspur, Himachal Pradesh, India
Correspondence Address:
Kapil Sharma
Department of General Medicine, AIIMS, Bilaspur, Himachal Pradesh
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/JCDM.JCDM_2_22
|
|
|
Diabetes mellitus is a major health problem globally that increases the economic burden of every country. According to the International Diabetes Federation (IDF) in 2021, 1 in 10 adults are living with diabetes. About 352 million adults have uncontrolled glycemic profiles worldwide. Diabetes is likely to affect 552 million people worldwide by 2030. Diabetes and its complications are emerging as the leading cause of morbidity and mortality. Diabetes neuropathies are estimated to affect approximately 50% of people suffering with diabetes. Neuropathy, the most prevalent microvascular complication of diabetes mellitus, includes distal symmetric polyneuropathy, radiculoplexus neuropathy, autonomic neuropathy, mononeuropathy, and treatment-induced neuropathy. Early diagnosis and appropriate management of diabetic neuropathy are essential to alleviate disabling symptoms and to improve the quality of life of patients. This review discusses clinical manifestations and evaluation of diabetic neuropathies as well as appropriate objective tests helpful in diagnosing diabetic neuropathies. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
